The Arab Drug Company

E£257.96As of Sun 8 Nov 2026, 12:00 UTC
EGX:ADCIHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 63.48%
Div yield 1.94%
ROE 38.61%
Pharmaceutical Preparations
Beta (5Y) 0.48
PE TTM 13.32
TSR TTM 19.11%
Mkt cap E£3.096B
ROIC 24.76%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£328
27.29%
219.93%
Hold 12|12|9|10|8
2Q26
3Q26
4Q26
1Q27
Earnings per shareE£
4.01
4.20
4.63
5.01
15.91%
21.73%
21.81%
31.45%
RevenueE£M
160.2
159.4
165.8
170.0
13.26%
7.10%
11.20%
7.86%
Peers (US$58.02M)
Cap (US$)
PE
124.0M
14.37x
83.40M
27.22x
57.85M
8.731x
Capital
TTM
5Y
10Y
Leveragex
0.098
0.243
0.221
EBIT/Intx
1.831
0.180
0.181
Own earn%
126.81
25.64
47.23
Sh yield%
28.61
53.98
55.62
Owners
Insiders/Inst%
13.99
26.43
Short interest%
4.50
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–8
$1 testx
0.3
Incr. ROIC%
6